Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Research article

The association between parity and metabolic syndrome and its components in normal-weight postmenopausal women in China

Authors: Mengte Shi, Xinhe Zhou, Chao Zheng, Youjin Pan

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Background

Studies analyzing the association between parity and normal-weight metabolic syndrome (MetS) in postmenopausal women of normal weight remain limited, this study aimed to explore the association between parity and MetS among Chinese normal-weight postmenopausal women.

Methods

In total, 776 normal-weight undiagnosed type 2 diabetes postmenopausal women who visited the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University for a routine health check-up between 1 January 2017 and 31 December 2019 were included in the cross-sectional study. All individuals had fully completed information records encompassing standardized electronic medical records, physical examinations, and biochemical measurements. Metabolic health was defined as fewer than 2 parameters of the MetS were present, in combination with normal weight. Continuous variables which were normally distributed were expressed as means and standard deviation. Comparisons among normally distributed continuous variables were made using one-way ANOVA while that among non-normal distribution parameters were made using Kruskal-Wallis. The association between parity and MetS was analyzed using multivariate logistic regression. All of the analyses were performed with SPSS statistical software (Version 23.0, SPSS, Inc., Chicago, IL, USA) and the statistical software package EmpowerStats (http://​www.​empowerstats.​com, X&Y Solutions, Inc., Boston, MA).

Results

After adjusting for potential confounding factors including hip circumference, parity was failed to show a significantly relationship with MetS in normal-weight women(P=0.054). Women with a higher parity (≥3) had an increased OR of abdominal obesity, while the OR (95% CI) of the parity 3 group was 2.06 (1.13, 3.77) and that of the parity ≥4 group was 3.08(1.42, 6.66) the P for trend was 0.002 after adjusting for potential confounding factors. No significant differences were detected for other metabolic disorders including high levels of triglycerides (TG), blood pressure, fasting plasma glucose (FPG), and decreased high-density lipoprotein cholesterol (HDL-C) in different parity groups.

Conclusions

Higher parity was not associated with a higher risk of MetS in normal weight Chinese postmenopausal women. As for the components of MetS, only waist circumference was associated with multiparity even after controlling for hip circumference.
Literature
1.
go back to reference Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds R, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet (London, England). 2005;365(9468):1398–405.CrossRef Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds R, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet (London, England). 2005;365(9468):1398–405.CrossRef
2.
go back to reference Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta. 2010;411(9–10):705–9.PubMedCrossRef Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta. 2010;411(9–10):705–9.PubMedCrossRef
3.
go back to reference Lao XQ, Zhang YH, Wong MC, Xu YJ, Xu HF, Nie SP, et al. The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern China. BMC Public Health. 2012;12:64.PubMedPubMedCentralCrossRef Lao XQ, Zhang YH, Wong MC, Xu YJ, Xu HF, Nie SP, et al. The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern China. BMC Public Health. 2012;12:64.PubMedPubMedCentralCrossRef
4.
go back to reference Xi B, He D, Hu Y, Zhou D. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China health and nutrition survey in 2009. Prev Med. 2013;57(6):867–71.PubMedPubMedCentralCrossRef Xi B, He D, Hu Y, Zhou D. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China health and nutrition survey in 2009. Prev Med. 2013;57(6):867–71.PubMedPubMedCentralCrossRef
5.
go back to reference Lan Y, Mai Z, Zhou S, Liu Y, Li S, Zhao Z, et al. Prevalence of metabolic syndrome in China: an up-dated cross-sectional study. PLoS One. 2018;13(4):e0196012.PubMedPubMedCentralCrossRef Lan Y, Mai Z, Zhou S, Liu Y, Li S, Zhao Z, et al. Prevalence of metabolic syndrome in China: an up-dated cross-sectional study. PLoS One. 2018;13(4):e0196012.PubMedPubMedCentralCrossRef
6.
go back to reference Zhang Y, Fu J, Yang S, Yang M, Liu A, Wang L, et al. Prevalence of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) in Chinese Beijing urban subjects. Biosci Trends. 2017;11(4):418–26.PubMedCrossRef Zhang Y, Fu J, Yang S, Yang M, Liu A, Wang L, et al. Prevalence of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) in Chinese Beijing urban subjects. Biosci Trends. 2017;11(4):418–26.PubMedCrossRef
7.
go back to reference Zheng Q, Lin W, Liu C, Zhou Y, Chen T, Zhang L, et al. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population. BMC Public Health. 2020;20(1):487.PubMedPubMedCentralCrossRef Zheng Q, Lin W, Liu C, Zhou Y, Chen T, Zhang L, et al. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population. BMC Public Health. 2020;20(1):487.PubMedPubMedCentralCrossRef
8.
go back to reference Buscemi S, Chiarello P, Buscemi C, Corleo D, Massenti MF, Barile AM, et al. Characterization of metabolically healthy obese people and metabolically unhealthy Normal-weight people in a general population cohort of the ABCD study. J Diabetes Res. 2017;2017:9294038.PubMedPubMedCentralCrossRef Buscemi S, Chiarello P, Buscemi C, Corleo D, Massenti MF, Barile AM, et al. Characterization of metabolically healthy obese people and metabolically unhealthy Normal-weight people in a general population cohort of the ABCD study. J Diabetes Res. 2017;2017:9294038.PubMedPubMedCentralCrossRef
9.
go back to reference Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.PubMedCrossRef Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.PubMedCrossRef
10.
go back to reference Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8(7):616–27.PubMedCrossRef Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8(7):616–27.PubMedCrossRef
11.
go back to reference Wildman R, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24.CrossRefPubMed Wildman R, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24.CrossRefPubMed
12.
go back to reference Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956–66.PubMedCrossRef Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956–66.PubMedCrossRef
13.
go back to reference Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168(5):4761–8.PubMedCrossRef Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168(5):4761–8.PubMedCrossRef
14.
go back to reference Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the nurses’ health study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714–24.PubMedCrossRef Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the nurses’ health study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714–24.PubMedCrossRef
15.
go back to reference Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J. 2018;39(5):397–406.PubMedCrossRef Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J. 2018;39(5):397–406.PubMedCrossRef
16.
go back to reference Trikudanathan S, Pedley A, Massaro JM, Hoffmann U, Seely EW, Murabito JM, et al. Association of female reproductive factors with body composition: the Framingham heart study. J Clin Endocrinol Metab. 2013;98(1):236–44.PubMedCrossRef Trikudanathan S, Pedley A, Massaro JM, Hoffmann U, Seely EW, Murabito JM, et al. Association of female reproductive factors with body composition: the Framingham heart study. J Clin Endocrinol Metab. 2013;98(1):236–44.PubMedCrossRef
17.
go back to reference Li J, Hua S, Chen GC, Strizich G, Kuniholm MH, Shan Z, et al. Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. Liver Int. 2020;40(8):1883.PubMedCrossRefPubMedCentral Li J, Hua S, Chen GC, Strizich G, Kuniholm MH, Shan Z, et al. Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. Liver Int. 2020;40(8):1883.PubMedCrossRefPubMedCentral
18.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640–5.PubMedCrossRef Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640–5.PubMedCrossRef
19.
go back to reference Stefan N, Schick F, Haring HU. Causes, characteristics, and consequences of metabolically unhealthy Normal weight in humans. Cell Metab. 2017;26(2):292–300.PubMedCrossRef Stefan N, Schick F, Haring HU. Causes, characteristics, and consequences of metabolically unhealthy Normal weight in humans. Cell Metab. 2017;26(2):292–300.PubMedCrossRef
20.
go back to reference Lee Y, Lee HN, Kim SJ, Koo J, Lee KE, Shin JE. Higher parity and risk of metabolic syndrome in Korean postmenopausal women: Korea National Health and nutrition examination survey 2010-2012. J Obstet Gynaecol Res. 2018;44(11):2045–52.PubMedCrossRef Lee Y, Lee HN, Kim SJ, Koo J, Lee KE, Shin JE. Higher parity and risk of metabolic syndrome in Korean postmenopausal women: Korea National Health and nutrition examination survey 2010-2012. J Obstet Gynaecol Res. 2018;44(11):2045–52.PubMedCrossRef
21.
go back to reference Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, Schooling M, et al. Parity and the metabolic syndrome in older Chinese women: the Guangzhou biobank cohort study. Clin Endocrinol. 2006;65(4):460–9.CrossRef Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, Schooling M, et al. Parity and the metabolic syndrome in older Chinese women: the Guangzhou biobank cohort study. Clin Endocrinol. 2006;65(4):460–9.CrossRef
22.
go back to reference Akter S, Jesmin S, Rahman M, Islam M, Khatun M, Yamaguchi N, et al. Higher gravidity and parity are associated with increased prevalence of metabolic syndrome among rural Bangladeshi women. PLoS One. 2013;8(8):e68319.PubMedPubMedCentralCrossRef Akter S, Jesmin S, Rahman M, Islam M, Khatun M, Yamaguchi N, et al. Higher gravidity and parity are associated with increased prevalence of metabolic syndrome among rural Bangladeshi women. PLoS One. 2013;8(8):e68319.PubMedPubMedCentralCrossRef
23.
go back to reference Vladutiu C, Siega-Riz A, Sotres-Alvarez D, Stuebe A, Ni A, Tabb K, et al. Parity and components of the metabolic syndrome among US Hispanic/Latina women: results from the Hispanic community health study/study of Latinos. Circ Cardiovasc Qual Outc. 2016;9:S62–9.CrossRef Vladutiu C, Siega-Riz A, Sotres-Alvarez D, Stuebe A, Ni A, Tabb K, et al. Parity and components of the metabolic syndrome among US Hispanic/Latina women: results from the Hispanic community health study/study of Latinos. Circ Cardiovasc Qual Outc. 2016;9:S62–9.CrossRef
24.
go back to reference Wu J, Xu G, Shen L, Zhang Y, Song L, Yang S, et al. Parity and risk of metabolic syndrome among Chinese women. J Women’s Health (2002). 2015;24(7):602–7.CrossRef Wu J, Xu G, Shen L, Zhang Y, Song L, Yang S, et al. Parity and risk of metabolic syndrome among Chinese women. J Women’s Health (2002). 2015;24(7):602–7.CrossRef
25.
go back to reference Ortiz AP, Suarez E, Beauchamp G, Romaguera J, Soto-Salgado M, Perez CM. Correlates of the metabolic syndrome among a sample of women in the San Juan metropolitan area of Puerto Rico. Metab Syndr Relat Disord. 2010;8(3):235–42.PubMedPubMedCentralCrossRef Ortiz AP, Suarez E, Beauchamp G, Romaguera J, Soto-Salgado M, Perez CM. Correlates of the metabolic syndrome among a sample of women in the San Juan metropolitan area of Puerto Rico. Metab Syndr Relat Disord. 2010;8(3):235–42.PubMedPubMedCentralCrossRef
26.
go back to reference Yao Y, Liu H, Wang X, Feng X, Gao L, Li D, et al. Effect of body mass index on the associations between parity and metabolic syndrome and its components among northern Chinese women. Biomed Environ Sci. 2020;33(1):11–8.PubMed Yao Y, Liu H, Wang X, Feng X, Gao L, Li D, et al. Effect of body mass index on the associations between parity and metabolic syndrome and its components among northern Chinese women. Biomed Environ Sci. 2020;33(1):11–8.PubMed
27.
go back to reference Esmaillzadeh A, Mirmiran P, Moeini SH, Azizi F. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol. 2006;108(3):338–45.PubMedCrossRef Esmaillzadeh A, Mirmiran P, Moeini SH, Azizi F. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol. 2006;108(3):338–45.PubMedCrossRef
28.
go back to reference Chen G, Arthur R, Iyengar N, Kamensky V, Xue X, Wassertheil-Smoller S, et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019;40(34):2849–55.PubMedPubMedCentralCrossRef Chen G, Arthur R, Iyengar N, Kamensky V, Xue X, Wassertheil-Smoller S, et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019;40(34):2849–55.PubMedPubMedCentralCrossRef
29.
go back to reference Blaudeau TE, Hunter GR, Sirikul B. Intra-abdominal adipose tissue deposition and parity. Int J Obes. 2006;30(7):1119–24.CrossRef Blaudeau TE, Hunter GR, Sirikul B. Intra-abdominal adipose tissue deposition and parity. Int J Obes. 2006;30(7):1119–24.CrossRef
30.
go back to reference Koch E, Bogado M, Araya F, Romero T, Díaz C, Manriquez L, et al. Impact of parity on anthropometric measures of obesity controlling by multiple confounders: a cross-sectional study in Chilean women. J Epidemiol Community Health. 2008;62(5):461–70.PubMedCrossRef Koch E, Bogado M, Araya F, Romero T, Díaz C, Manriquez L, et al. Impact of parity on anthropometric measures of obesity controlling by multiple confounders: a cross-sectional study in Chilean women. J Epidemiol Community Health. 2008;62(5):461–70.PubMedCrossRef
31.
go back to reference Mansour A, Ajeel N. Parity is associated with increased waist circumference and other anthropometric indices of obesity. Eat Weight Disord. 2009;14:e50–5.PubMedCrossRef Mansour A, Ajeel N. Parity is associated with increased waist circumference and other anthropometric indices of obesity. Eat Weight Disord. 2009;14:e50–5.PubMedCrossRef
32.
go back to reference Li W, Wang Y, Shen L, Song L, Li H, Liu B, et al. Association between parity and obesity patterns in a middle-aged and older Chinese population: a cross-sectional analysis in the Tongji-Dongfeng cohort study. Nutr Metab. 2016;13:72.CrossRef Li W, Wang Y, Shen L, Song L, Li H, Liu B, et al. Association between parity and obesity patterns in a middle-aged and older Chinese population: a cross-sectional analysis in the Tongji-Dongfeng cohort study. Nutr Metab. 2016;13:72.CrossRef
33.
go back to reference Athyros V, Doumas M, Imprialos K, Stavropoulos K, Georgianou E, Katsimardou A, et al. Diabetes and lipid metabolism. Hormones (Athens, Greece). 2018;17(1):61–7.CrossRef Athyros V, Doumas M, Imprialos K, Stavropoulos K, Georgianou E, Katsimardou A, et al. Diabetes and lipid metabolism. Hormones (Athens, Greece). 2018;17(1):61–7.CrossRef
34.
35.
go back to reference Magiakou M, Mastorakos G, Rabin D, Margioris A, Dubbert B, Calogero A, et al. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin Endocrinol. 1996;44(4):419–28.CrossRef Magiakou M, Mastorakos G, Rabin D, Margioris A, Dubbert B, Calogero A, et al. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin Endocrinol. 1996;44(4):419–28.CrossRef
36.
go back to reference Xu B, Zhang J, Xu Y, Lu J, Xu M, Chen Y, et al. Association between history of abortion and metabolic syndrome in middle-aged and elderly Chinese women. Front Med. 2013;7(1):132–7.PubMedCrossRef Xu B, Zhang J, Xu Y, Lu J, Xu M, Chen Y, et al. Association between history of abortion and metabolic syndrome in middle-aged and elderly Chinese women. Front Med. 2013;7(1):132–7.PubMedCrossRef
37.
go back to reference Liu Y, Lu J, Xu M, Xu Y, Li M, Wang T, et al. Association between history of abortion and nonalcoholic fatty liver disease in middle-aged and elderly Chinese women. Ann Epidemiol. 2013;23(3):119–23.PubMedCrossRef Liu Y, Lu J, Xu M, Xu Y, Li M, Wang T, et al. Association between history of abortion and nonalcoholic fatty liver disease in middle-aged and elderly Chinese women. Ann Epidemiol. 2013;23(3):119–23.PubMedCrossRef
Metadata
Title
The association between parity and metabolic syndrome and its components in normal-weight postmenopausal women in China
Authors
Mengte Shi
Xinhe Zhou
Chao Zheng
Youjin Pan
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00674-6

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue